Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

May 31, 2001

Conditions

Healthy

Interventions

DRUG

Asasantin ER, new formulation I

DRUG

Asasantin ER, new formulation II

DRUG

Asasantin ER, present commercial formulation